Regional
Confederated Tribes of Grand Ronde Department of Emergency Services
Confederated Tribes of Grand Ronde Department of Emergency Services (OR) carries 51 drugs across 220 dose entries in its current published protocol, effective 2025-01-06.
Drugs and doses51
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 1000 mg | IV | not captured | standing | pages 58, 94 |
| Mild to moderate pain | adult | 650–1000 mg | PO | not captured | standing | pages 58, 94 |
| Mild to moderate pain | peds | 15 mg/kg | PO | not captured | standing | pages 58, 94 |
Activated Charcoal
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 g/kg | PO | not captured | standing | pages 73, 95 |
| Other | peds | 1 g/kg | PO | not captured | standing | pages 73, 95 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| SVT | adult | 6 mg | IV | not captured | standing | pages 45, 46, 96 |
| SVT | peds | 0.1 mg/kg | IV | not captured | standing | pages 45, 46, 96 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | pages 78, 97 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | pages 78, 97 |
| Hyperkalemia | peds | 2.5–10 mg | NEB | not captured | standing | pages 59, 97 |
| Other | adult | 2.5 mg | NEB | not captured | standing | pages 74, 97 |
| Other | peds | 2.5 mg | NEB | not captured | standing | pages 74, 97 |
| Other | peds | 2.5 mg | NEB | not captured | standing | page 80 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 150 mg | IV/IO | not captured | standing | pages 48, 49, 98, 99 |
| Other | adult | 150 mg | IV/IO | not captured | standing | pages 45, 98 |
| Other | adult | 150 mg | IV/IO | not captured | standing | pages 41, 98 |
| Other | adult | 150 mg | IV/IO | not captured | standing | pages 51, 98 |
| Other | peds | 2.5 mg/kg | IV/IO | not captured | standing | pages 48, 49, 98, 99 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | pages 38, 98, 99 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | pages 38, 98, 99 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 324 mg | PO | not captured | standing | pages 51, 100 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | pages 42, 101, 102 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 42, 101, 102 |
| Other | adult | 0.5 mg | IV/IO | not captured | standing | pages 101, 102, 165 |
| Other | adult | 1–2 mg | IV/IO/IM | not captured | standing | pages 74, 101, 102 |
| Other | adult | 3–5 mg | IV/IO/IM | not captured | standing | pages 74, 101, 102 |
| Other | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 101, 102, 165 |
| Other | peds | 0.05 mg/kg | IV/IO/IM | not captured | standing | pages 74, 101, 102 |
| Other | peds | 0.05 mg/kg | IV/IO/IM | not captured | standing | pages 74, 101, 102 |
Buprenorphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 16 mg | SL | not captured | standing | page 103 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1–3 g | IV/IO | not captured | standing | page 104 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.6 mL/kg | IV/IO | not captured | standing | page 104 |
| Burns | adult | 3 g | TOP | not captured | standing | page 104 |
| Hyperkalemia | adult | 3 g | IV/IO | not captured | standing | pages 59, 104 |
| Hyperkalemia | adult | 3 g | IV/IO | not captured | standing | pages 38, 104 |
| Hyperkalemia | peds | 0.6 mL/kg | IV/IO | not captured | standing | pages 59, 104 |
| Other | adult | 2.5% solution | NEB | not captured | standing | page 104 |
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 10 mg | IV/IO/IM/PO | not captured | standing | page 105 |
| Anaphylaxis | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 105 |
| Croup | adult | 10 mg | IV/IO/IM/PO | not captured | standing | page 105 |
| Croup | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 105 |
| Other | adult | 10 mg | IV/IO/IM/PO | not captured | standing | page 105 |
| Other | adult | 10 mg | IV/IO/IM/PO | not captured | standing | page 105 |
| Other | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 105 |
| Other | peds | 10 mg | IV/IO/IM/PO | not captured | standing | page 105 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 10–25 g | IV/IO | not captured | standing | page 106 |
| Hypoglycemia | peds | 5 mL/kg | IV/IO | not captured | standing | page 106 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 10 mg | IV | not captured | standing | page 107 |
| Atrial fibrillation with RVR | adult | 10 mg | IV | not captured | standing | page 107 |
| SVT | adult | 10 mg | IV | not captured | standing | page 107 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 1 mg/kg | IV/IM | not captured | standing | page 108 |
| Allergic reaction | peds | 1 mg/kg | IV/IM | not captured | standing | page 108 |
| Anaphylaxis | adult | 1 mg/kg | IV/IM | not captured | standing | page 108 |
| Anaphylaxis | peds | 1 mg/kg | IV/IM | not captured | standing | page 108 |
| Dystonic reaction | adult | 1 mg/kg | IV/IM | not captured | standing | page 108 |
| Dystonic reaction | peds | 1 mg/kg | IV/IM | not captured | standing | page 108 |
| Procedural sedation | peds | 1 mg/kg | IV/IM | not captured | standing | page 108 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 2–10 mcg/kg | IV | not captured | standing | page 109 |
| Bradycardia | peds | 2–10 mcg/kg | IV | not captured | standing | page 109 |
| Cardiogenic shock | adult | 5–20 mcg/kg | IV | not captured | standing | page 109 |
| Cardiogenic shock | peds | 5–20 mcg/kg | IV | not captured | standing | page 109 |
Droperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 0.625 mg | IV | not captured | standing | pages 110, 111 |
| Procedural sedation | adult | 2.5–5 mg | IV/IO/IM | not captured | standing | page 111 |
| Procedural sedation | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 111 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3–0.5 mg | IM | not captured | standing | pages 31, 32, 112 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | pages 31, 32, 112 |
| Asthma / bronchospasm | adult | 0.3–0.5 mg | IM | not captured | standing | pages 78, 112 |
| Asthma / bronchospasm | peds | 0.01 mg/kg | IM | not captured | standing | pages 78, 112 |
| Bradycardia | adult | 2–10 mcg | IV/IO | not captured | standing | pages 42, 43, 112 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 42, 43, 112 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | pages 38, 112 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 38, 112 |
| Croup | peds | 5 mg | NEB | not captured | standing | pages 80, 112, 113 |
| Hypotension / shock | adult | 10–20 mcg | IV/IO | not captured | standing | page 113 |
| Hypotension / shock | peds | 1 mcg/kg | IV/IO | not captured | standing | page 113 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Procedural sedation | adult | 0.15 mg/kg | IV/IO | not captured | standing | page 114 |
| Procedural sedation | peds | 0.15 mg/kg | IV/IO | not captured | standing | page 114 |
| RSI induction | adult | 0.3 mg/kg | IV/IO | not captured | standing | page 114 |
| RSI induction | peds | 0.3 mg/kg | IV/IO | not captured | standing | page 114 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 50 mcg | IV/IO | not captured | standing | pages 37, 116 |
| Cardiac arrest | peds | 50 mcg | IV/IO | not captured | standing | pages 37, 116 |
| Mild to moderate pain | adult | 50–100 mcg | IV/IN | not captured | standing | pages 70, 71, 115, 116 |
| Mild to moderate pain | adult | 50–100 mcg | IM | not captured | standing | pages 70, 71, 115, 116 |
| Mild to moderate pain | peds | 1–2 mcg/kg | IM | not captured | standing | pages 70, 71, 115, 116 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IN | not captured | standing | pages 70, 71, 115, 116 |
| Post-intubation sedation | adult | 50–100 mcg | IV/IO | not captured | standing | page 116 |
| Post-intubation sedation | peds | 1 mcg/kg | IV/IO | not captured | standing | page 116 |
Furosemide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 20 mg | IV | not captured | standing | page 117 |
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 1 mg | IM | not captured | standing | pages 29, 30, 55, 118 |
| Other | adult | 1 mg | IV/IM | not captured | standing | pages 31, 118 |
Haloperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 1.25 mg | IV/IM | not captured | standing | pages 64, 121, 231 |
| Procedural sedation | adult | 5–10 mg | IV/IO/IM | not captured | standing | pages 24, 25, 26, 120, 121 |
Hydromorphone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 0.25–0.5 mg | IV | not captured | standing | pages 70, 122, 123, 231 |
| Mild to moderate pain | adult | 0.5–1 mg | IM | not captured | standing | pages 70, 122, 123, 231 |
| Mild to moderate pain | peds | 0.01 mg/kg | IV | not captured | standing | pages 70, 122, 123, 231 |
| Mild to moderate pain | peds | 0.01 mg/kg | IM | not captured | standing | pages 70, 122, 123, 231 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV/IO | not captured | standing | pages 34, 73, 74, 124 |
| Cyanide poisoning | peds | 70 mg/kg | IV/IO | not captured | standing | pages 34, 73, 74, 124 |
Ibuprofen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 200–600 mg | PO | not captured | standing | pages 58, 125, 126 |
| Fever | peds | 10 mg/kg | PO | not captured | standing | pages 58, 125, 126 |
| Mild to moderate pain | adult | 200–600 mg | PO | not captured | standing | pages 58, 70, 125, 126 |
| Mild to moderate pain | peds | 10 mg/kg | PO | not captured | standing | pages 58, 70, 125, 126 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | pages 78, 127 |
| Asthma / bronchospasm | peds | 0.5 mg | NEB | not captured | standing | pages 78, 127 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 12.5–25 mg | IV/IO | not captured | standing | pages 71, 128 |
| Mild to moderate pain | adult | 25–50 mg | IM | not captured | standing | page 128 |
| Mild to moderate pain | peds | 0.3 mg/kg | IV/IO | not captured | standing | pages 71, 128 |
| Post-intubation sedation | adult | 0.5–1 mg/kg | IV/IO | not captured | standing | pages 128, 165 |
| RSI induction | adult | 200 mg | IV/IO | not captured | standing | pages 128, 164 |
| RSI induction | peds | 2 mg/kg | IV/IO | not captured | standing | pages 128, 164 |
| Seizure | adult | 1 mg/kg | IV/IO | not captured | standing | page 128 |
| Seizure | adult | 2 mg/kg | IM | not captured | standing | page 128 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 15 mg | IV | not captured | standing | page 129 |
| Mild to moderate pain | adult | 30 mg | IM | not captured | standing | page 129 |
| Mild to moderate pain | peds | 0.5 mg/kg | IV | not captured | standing | page 129 |
| Mild to moderate pain | peds | 1 mg/kg | IM | not captured | standing | page 129 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10 mg | IV | not captured | standing | page 130 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 131 |
| Other | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 131 |
| Other | peds | 1.5 mg/kg | IV/IO | not captured | standing | page 131 |
| Other | peds | 1.5 mg/kg | IV/IO | not captured | standing | page 131 |
| Mild to moderate pain | adult | 40 mg | IO | not captured | standing | page 131 |
| Mild to moderate pain | peds | 0.5 mg/kg | IO | not captured | standing | page 131 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 0.5–1 mg | IV/IM | not captured | standing | page 133 |
| Other | adult | 1–2 mg | IV/IO | not captured | standing | page 133 |
| Other | adult | 1 mg | IV/IO | not captured | standing | page 133 |
| Other | adult | 2 mg | IM | not captured | standing | page 133 |
| Other | peds | 0.05 mg/kg | IV/IO | not captured | standing | page 133 |
| Other | peds | 0.1 mg/kg | IM | not captured | standing | page 133 |
| Post-intubation sedation | adult | 1–2 mg | IV/IO | not captured | standing | pages 132, 133 |
| Post-intubation sedation | peds | 0.05 mg/kg | IV/IO | not captured | standing | pages 132, 133 |
| Procedural sedation | adult | 2 mg | IV/IO | not captured | standing | pages 132, 133 |
| Procedural sedation | adult | 2 mg | IM | not captured | standing | pages 132, 133 |
| Procedural sedation | peds | 0.05 mg/kg | IV/IO | not captured | standing | pages 132, 133 |
| Procedural sedation | peds | 0.05 mg/kg | IM | not captured | standing | pages 132, 133 |
| Procedural sedation | peds | 0.1 mg/kg | IM | not captured | standing | pages 132, 133 |
| Seizure | adult | 2 mg | IV/IO | not captured | standing | pages 132, 133 |
| Seizure | adult | 4 mg | IM | not captured | standing | pages 132, 133 |
| Seizure | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 132, 133 |
| Seizure | peds | 0.2 mg/kg | IM | not captured | standing | pages 132, 133 |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV | not captured | standing | page 134 |
| Other | adult | 2 g | IV | not captured | standing | page 134 |
| Other | adult | 4 g | IV/IO | not captured | standing | page 134 |
| Wide-complex tachycardia | adult | 2 g | IV/IO | not captured | standing | page 134 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2.5 mg | IV/IO | not captured | standing | pages 37, 135 |
| Post-intubation sedation | adult | 2.5–5 mg | IV/IO | not captured | standing | pages 135, 136 |
| Post-intubation sedation | peds | 0.05 mg/kg | IV/IO | not captured | standing | pages 135, 136 |
| Procedural sedation | adult | 2.5–5 mg | IV/IO | not captured | standing | pages 133, 135, 136 |
| Procedural sedation | adult | 2.5 mg | IV/IO | not captured | standing | pages 133, 135, 136 |
| Procedural sedation | adult | 5 mg | IM | not captured | standing | pages 133, 135, 136 |
| Procedural sedation | adult | 5 mg | IM | not captured | standing | pages 133, 135, 136 |
| Procedural sedation | adult | 5 mg | IM | not captured | standing | pages 135, 136 |
| Procedural sedation | peds | 0.05 mg/kg | IV/IO | not captured | standing | pages 133, 135, 136 |
| Procedural sedation | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 133, 135, 136 |
| Procedural sedation | peds | 0.1 mg/kg | IM | not captured | standing | pages 133, 135, 136 |
| Procedural sedation | peds | 0.1 mg/kg | IM | not captured | standing | pages 133, 135, 136 |
| Procedural sedation | peds | 0.1 mg/kg | IM | not captured | standing | pages 135, 136 |
| Seizure | adult | 10 mg | IM/IN | not captured | standing | pages 82, 135, 136 |
| Seizure | adult | 5 mg | IV/IO | not captured | standing | pages 82, 135, 136 |
| Seizure | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 82, 135, 136 |
| Seizure | peds | 0.3 mg/kg | IM/IN | not captured | standing | pages 82, 135, 136 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 2–8 mg | IV | not captured | standing | page 137 |
| Mild to moderate pain | adult | 5–10 mg | IM | not captured | standing | page 137 |
| Mild to moderate pain | peds | 0.1 mg/kg | IV | not captured | standing | page 137 |
| Mild to moderate pain | peds | 0.1 mg/kg | IM | not captured | standing | page 137 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5 mg | IV | not captured | standing | pages 29, 30, 138 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | pages 29, 30, 138 |
| Other | peds | 0.1 mg/kg | IM/IN | not captured | standing | pages 29, 30, 138 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | pages 51, 139 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | pages 77, 139 |
| Other | adult | 0.4 mg | SL | not captured | standing | pages 77, 140 |
| Other | adult | 1 mg | IV | not captured | standing | pages 77, 140 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 4–24 mcg | IV | not captured | standing | page 141 |
| Hypotension / shock | peds | 0.1–0.4 mcg/kg | IV | not captured | standing | page 141 |
Olanzapine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 10 mg | PO | not captured | standing | page 142 |
| Agitation | peds | 2.5–5 mg | PO | not captured | standing | page 142 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV/IM | not captured | standing | page 143 |
| Nausea / vomiting | adult | 8 mg | PO | not captured | standing | page 143 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/IM | not captured | standing | page 143 |
| Nausea / vomiting | peds | 2–4 mg | PO | not captured | standing | page 143 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | One tube | PO | not captured | standing | pages 55, 119 |
| Hypoglycemia | peds | One tube | PO | not captured | standing | pages 55, 119 |
Oxymetazoline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 spray | IN | not captured | standing | page 145 |
| Other | peds | 2 spray | IN | not captured | standing | page 145 |
Oxytocin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 10 unit | IV/IM | not captured | standing | page 146 |
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1200 mg | IV/IO | not captured | standing | pages 148, 280 |
| Other | adult | 1800 mg | IV/IO | not captured | standing | pages 148, 280 |
Promethazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 12.5 mg | IV | not captured | standing | pages 64, 147 |
| Nausea / vomiting | adult | 25 mg | IM | not captured | standing | pages 64, 147 |
| Nausea / vomiting | peds | 0.25–1 mg/kg | IV | not captured | standing | pages 64, 147 |
| Nausea / vomiting | peds | 0.25–1 mg/kg | IM | not captured | standing | pages 64, 147 |
Proparacaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Burns | adult | 1 drop | not captured | not captured | standing | pages 57, 149 |
| Burns | peds | 1 drop | not captured | not captured | standing | pages 57, 149 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5 mg/kg | IV/IO | not captured | standing | pages 150, 166 |
| Other | peds | 0.5 mg/kg | IV/IO | not captured | standing | pages 150, 166 |
| RSI induction | adult | 1.2 mg/kg | IV/IO | not captured | standing | pages 150, 164 |
| RSI induction | peds | 1.2 mg/kg | IV/IO | not captured | standing | pages 150, 164 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Crush injury | adult | 50 mEq | IV/IO | not captured | standing | page 151 |
| Hyperkalemia | adult | 50 mEq | IV/IO | not captured | standing | pages 59, 151 |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 74, 151 |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | page 151 |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 91, 92, 151 |
| Other | adult | 2.5 mL | NEB | not captured | standing | pages 74, 151 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 74, 151 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | page 151 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 91, 92, 151 |
| Other | peds | 2.5 mL | NEB | not captured | standing | pages 74, 151 |
Sodium Thiosulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 50 mL | IV | not captured | standing | pages 34, 152 |
| Cyanide poisoning | peds | 1.65 mL/kg | IV | not captured | standing | pages 34, 152 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1.5 mg/kg | IV/IO | not captured | standing | pages 153, 164 |
| RSI induction | peds | 1.5–2 mg/kg | IV/IO | not captured | standing | pages 153, 164 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Head injury / TBI | adult | 2 g | IV/IO | not captured | standing | pages 91, 154 |
| Obstetric hemorrhage | adult | 2 g | IV/IO | not captured | standing | pages 68, 154 |
| Trauma / hemorrhage | adult | 2 g | IV/IO | not captured | standing | pages 85, 154 |
Vecuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.1 mg/kg | IV/IO | not captured | standing | pages 150, 166 |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 150, 166 |
| RSI induction | adult | 0.1 mg/kg | IV/IO | not captured | standing | pages 150, 166 |
| RSI induction | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 150, 166 |
Ziprasidone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Procedural sedation | adult | 10–20 mg | IM | not captured | standing | pages 25, 26, 27, 28, 156 |
| Procedural sedation | peds | 10 mg | IM | not captured | standing | pages 25, 26, 27, 28, 156 |